Dr Rajiv Sankaranarayanan
LightNews LightNews
drrajivsankar.bsky.social
Dr Rajiv Sankaranarayanan
@drrajivsankar.bsky.social
820 followers 640 following 46 posts
MBBS FRCP FESC FHFA PhD #heartfailure Cardiologist @LivHospitals Researcher, VW Clinical Lead NHSE GIRFT, BSH Board Councillor, ESC Digital Committee, BCS Digital Comms VP-elect, #YNWA #LiverpoolFootballClub #renalcancer survivor, skeet=my opinion
Posts Replies Media Videos
Reposted by Dr Rajiv Sankaranarayanan
jcardfail.bsky.social
🚨More #HFSA2025 sim pubs out today @Jcardfail! 🚨

Hemodynamics and crosstalk between HF & EP! 📃🫀
September 27, 2025 at 8:49 PM
Reposted by Dr Rajiv Sankaranarayanan
jcardfail.bsky.social
🚨 #HFSA2025 SimPub alert!

The Heart Failure Society America’s 2025 Annual Scientific Meeting kicks off today, and JCF has 12 simultaneous publications releasing during the meeting!
September 26, 2025 at 11:15 PM
drrajivsankar.bsky.social
#WorldHeartDay ❇️Exciting agenda on Sep 29th @liverpoolccs.bsky.social chaired by Prof Gregory Lip @lukaszkuzma.bsky.social delivers the Key Note Lecture. @worldheart.org @pumpingmarvellous.bsky.social @evertoninthecommunity.org @thebhf.bsky.social
September 27, 2025 at 8:35 PM
Reposted by Dr Rajiv Sankaranarayanan
drdavemd.bsky.social
Prevalence of pulmonary hypertension in HF is about 50%, with some variation depending on use of echo vs. RHC and HFpEF vs HFrEF. Unfortunately, the I2 heterogeneity is almost 100% onlinelibrary.wiley.com/doi/epdf/10.... #cardiosky
Prevalence of Pulmonary Hypertension in Individuals With Heart Failure: A Systematic Review and Meta‐Analysis
You have to enable JavaScript in your browser's settings in order to use the eReader.
onlinelibrary.wiley.com
September 27, 2025 at 4:49 PM
Reposted by Dr Rajiv Sankaranarayanan
ajpcardio.bsky.social
🫀 When heart failure meets CV prev, saving hearts is our focus.

@aspcardio.bsky.social & @hfsa.bsky.social Joint Scientific Statement, The Continuum of Prevention & Heart Failure in Cardiovascular Medicine, calls for a prevention-first approach at every stage.

www.sciencedirect.com/science/arti...
August 13, 2025 at 3:21 PM
Reposted by Dr Rajiv Sankaranarayanan
tumscvdri.bsky.social
The simple LENT index—using length of stay, prior ED visits, and NT-proBNP—best predicts 30-day death or readmission after #HeartFailure hospitalization. Accurate, easy, and practical! #RiskPrediction @drrajivsankar.bsky.social @mmamas1973.bsky.social onlinelibrary.wiley.com/doi/10.1002/...
Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and ...
onlinelibrary.wiley.com
July 9, 2025 at 6:02 AM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social
April 13, 2025 at 4:19 PM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
#Finerenone reduced the risk of CV death and total worsening HF events, and was well-tolerated, independent of glycaemic status in HFmrEF/HFpEF

@escardio.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @docbhardwaj.bsky.social

onlinelibrary.wiley.com/doi/full/10....
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, r...
onlinelibrary.wiley.com
April 13, 2025 at 4:34 PM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
Conduction system pacing: promoting the physiology to prevent HF

Background and Clinical perspectives of HBP and LBBP area in HF
link.springer.com/article/10.1...

#HF #CardioSky #CardioEd @cardioobdoc.bsky.social @drrajivsankar.bsky.social @annakatebarton.bsky.social @vietheartpa.bsky.social
April 5, 2025 at 12:43 AM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation

onlinelibrary.wiley.com/doi/10.1002/... #Impella #CardioSky #CardiogenicShock #LVADs
@drrajivsankar.bsky.social @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @hvanspall.bsky.social
April 5, 2025 at 12:45 AM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure

In 65 AHF patients, lymphatic flow (via ICG lymphangiography) predicted diuretic response.

#AHF #CardioSky #Lymphatics #AHF @shelleyzieroth.bsky.social @escardio.bsky.social @drrajivsankar.bsky.social
April 9, 2025 at 11:59 PM
Reposted by Dr Rajiv Sankaranarayanan
hancardiomd.bsky.social
Faster lower limb lymph flow was linked with better diuretic efficacy in AHF.

#CardioSky @escardio.bsky.social #EJHF @cardioobdoc.bsky.social @noshreza.bsky.social @novitham.bsky.social @drrajivsankar.bsky.social @vietheartpa.bsky.social

onlinelibrary.wiley.com/doi/10.1002/...
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure
Lower extremity lymphatic flow and diuretic response in acute heart failure (AHF). IV, intravenous. (Created in BioRender)
onlinelibrary.wiley.com
April 10, 2025 at 12:04 AM
Reposted by Dr Rajiv Sankaranarayanan
drrachelclarke.com
The dream team! So desperately hoping every one of you will be voted in by colleagues 💙
April 10, 2025 at 5:20 PM
Reposted by Dr Rajiv Sankaranarayanan
drasifqasim.bsky.social
Please encourage your FRCP colleagues to vote before Monday 14th April

Vote Asif Qasim for President

@drlkvaughan.bsky.social for VP
@respirologist.bsky.social Dr Philip Pearson for Council
@copddoc.bsky.social Prof Nick Hopkinson for Council

#TimeForChange
drasifqasim.bsky.social drasifqasim.bsky.social @drasifqasim.bsky.social · Feb 6
It’s an honour to be standing for election as president of the RCP

Thanks my proposers:
Prof Sir Richard Thompson
Dr Taryn Youngstein
Prof Sir Shakeel Qureshi

Details on the election website soon and more at asifqasim.co.uk

My vision is to restore the @RCPhysicians as the #VoiceofPhysicians
Dr Asif Qasim, MA PhD FRCP
Dr Asif Qasim MA PhD FRCP is a London-based Consultant Interventional Cardiologist and former NHS Clinical Director with a PhD in Cardiovascular Medicine. Dedicated to healthcare innovation, medical e...
asifqasim.co.uk
April 10, 2025 at 5:15 PM
drrajivsankar.bsky.social
#VoteAsifQasim #TimeForChange
drasifqasim.bsky.social drasifqasim.bsky.social @drasifqasim.bsky.social · Mar 31
Thank you for your votes & support in the RCP Election - your endorsements to #VoteAsifQasim send a powerful message.

We need a fresh start, with new leadership #TimeForChange.

I am committed to rebuilding pride in the RCP & restoring your #VoiceOfPhysicians

#VoteAsifQasim

asifqasim.co.uk/prcp
PRCP Election — Dr Asif Qasim, MA PhD FRCP
Dr Asif Qasim candidate for election at President of the Royal College of Physicians - restoring the RCP as the Voice of Physicians
asifqasim.co.uk
March 31, 2025 at 8:44 PM
Reposted by Dr Rajiv Sankaranarayanan
drasifqasim.bsky.social
Thank you for your votes & support in the RCP Election - your endorsements to #VoteAsifQasim send a powerful message.

We need a fresh start, with new leadership #TimeForChange.

I am committed to rebuilding pride in the RCP & restoring your #VoiceOfPhysicians

#VoteAsifQasim

asifqasim.co.uk/prcp
PRCP Election — Dr Asif Qasim, MA PhD FRCP
Dr Asif Qasim candidate for election at President of the Royal College of Physicians - restoring the RCP as the Voice of Physicians
asifqasim.co.uk
March 31, 2025 at 8:22 PM
Reposted by Dr Rajiv Sankaranarayanan
med-iqcardiology.bsky.social
More from Dr. Masri from Day 2 at #ACC.25...

Adding #Whycmr to the mix of risk in patients with #ATTR #cardiomyopathy. @accintouch.bsky.social #CardioSky #Cardiology #MedSky #ACC25
March 30, 2025 at 5:29 PM
Reposted by Dr Rajiv Sankaranarayanan
accintouch.bsky.social
Evolut Low Risk: Pts w/ severe #vhdAS who were treated w/ either #TAVR/surgery had comparable rates of all-cause mortality or disabling #stroke at 5️⃣ years. Valve durability & performance were also excellent in both groups. #ACC25

🔗 bit.ly/43wW1m7 #JACC @jaccjournals.bsky.social

#CardioSky #MedSky
March 30, 2025 at 5:35 PM
Reposted by Dr Rajiv Sankaranarayanan
accintouch.bsky.social
FLAVOUR-II: Novel #AI-Powered Imaging Technique Noninferior to IVUS in #PCI

Read the journal scan to learn more: bit.ly/4j8u8oP #ACC25

#CardioSky #MedSky
March 30, 2025 at 5:38 PM
Reposted by Dr Rajiv Sankaranarayanan
escardio.bsky.social
Roxana Mehran shares the breakthroughs from PROTECT-TAVI

#ESCTVOnTheRoad #ACC25
March 30, 2025 at 5:49 PM
Reposted by Dr Rajiv Sankaranarayanan
drmarthagulati.bsky.social
#ACC25 #cardiosky #EVOLUT

📎https://www.jacc.org/doi/10.1016/j.jacc.2025.03.004?utm_medium=print_qr&utm_source=author&utm_campaign=spub&utm_content=author
March 30, 2025 at 5:54 PM
Reposted by Dr Rajiv Sankaranarayanan
drmarthagulati.bsky.social
#ACC25 #LBCT 5 year #EVOLUT Trial
❤️Low risk patients with symptomatic AS: what are the 5y outcomes of Sx 🆚 TAVI
💔1/3 Female
💔 all-cause Mortality gap ⬇️ with time
💔 CV mortality ⬇️ for TAVI
💔more pacemaker with EVOLUT

💥EVOLUT IN LOW RISK PATIENTS SAFE ALTERNATIVE TO Sx
March 30, 2025 at 5:52 PM
Reposted by Dr Rajiv Sankaranarayanan
accintouch.bsky.social
MIGHTy-Heart: A program that delivered in-home visits from a trained paramedic team to people with #HeartFailure did not significantly reduce 30-day 🏥 readmissions or improve health status compared with standard follow-up 📞 calls. #ACC25

Learn more: bit.ly/41SPhOe

#CardioSky #MedSky
March 30, 2025 at 6:22 PM
Reposted by Dr Rajiv Sankaranarayanan
jaccjournals.bsky.social
In an individual patient data meta-analysis of 7,805 patients enrolled in 7 RCTs, Dr. @rohankhera.bsky.social and colleagues of @cardslab.bsky.social found evidence of superiority for tirzepatide in resolving metabolic syndrome www.jacc.org/doi/10.1016/...

#ACC25 #JACC #T2D #diabetes
March 30, 2025 at 6:57 PM
Reposted by Dr Rajiv Sankaranarayanan
drbenzigerheart.bsky.social
Dr. Amy Sarma:
Who needs monogenic genetic testing for #SCAD ?
✅Men
✅Aortic aneurysm
✅Family history
✅SCAD pt wanting pregnancy

Otherwise likely polygenic
@accintouch.bsky.social #acc25
#cvprev
March 30, 2025 at 7:01 PM